D
uring the last decade, use of anesthesia services for gastrointestinal endoscopy has trended upward. Anesthesia involvement with colonoscopy has increased from approximately 3.1% in 1989 to 34.4% in 2011 with significant regional variation, including proportions as high as 79.3% in Florida. 1, 2 Much of this growth has been in patients considered low-risk, suggesting that the additional spending may not be necessary. 3 Due in part to these increased costs, the Centers for Medicare and Medicaid Services has removed the value of moderate sedation from gastrointestinal endoscopy codes and created a separate Current Procedural Terminology code for the administration of moderate sedation beginning in 2017. 4 As a result, endoscopists who use anesthesia services for sedation can only bill for the underlying procedural code resulting in decreased procedural reimbursement.
Beyond financial costs, receipt of anesthesia services during colonoscopy may also increase procedural risks to patients, 1 although the literature is not uniform in this regard. Indeed, the data also suggest that use of propofol for sedation during colonoscopy leads to improved patient satisfaction and improved endoscopy unit efficiency. 5, 6 Given the financial costs of anesthesia services, the potential added risks, and the fact that most endoscopic procedures are still performed with moderate sedation, a better understanding of the optimal protocol for moderate sedation is warranted. Multiple studies have shown that midazolam and fentanyl are the pharmacologic agents of choice because of their efficacy, safety, cost, and efficiency in colonoscopy. [7] [8] [9] [10] Despite their widespread use, however, there is currently very little published data on the optimal method of dosing for these drugs. In a doubleblinded, randomized controlled trial published in the American Journal of Gastroenterology in 2000, Morrow et al 11 studied the effects of bolus versus titration dosed sedation for outpatient colonoscopies. The bolus intervention consisted of giving a single dose of midazolam and fentanyl based on gender, age, and weight. The primary outcomes of interest were patient satisfaction, physician time, adverse events, and cumulative medication doses. Although the study did not show a significant change in patient satisfaction, it did demonstrate a significant benefit in physician time, number of adverse events, and cumulative doses, favoring the bolus group.
Despite this evidence, the most recent practice guidelines from the American Society of Anesthesiologists (ASA) Task Force on Sedation and Analgesia by Non-Anesthesiologists recommends incremental dosing of sedative/analgesic drugs as opposed to a single dose based on patient size, weight, or age. 12 The American Society of Gastrointestinal Endoscopy recommended titration (incremental dosing) in its guidelines from 2003, 13 but more recent guidelines do not take a position on this issue, stating, "the choice of sedative is largely operator dependent and is based on maximizing patient comfort while minimizing risks." 14 Given the findings of Morrow et al 11 and market pressures to improve endoscopy unit efficiency and improve the patient experience, the Duke University Hospital endoscopy units transitioned from nurse-directed titration sedation to physician-directed bolus sedation in 2010. We undertook this retrospective analysis with an aim to understand the impact of implementation on endoscopy unit efficiency, patient safety, and patient satisfaction. Our hypothesis was that bolus sedation would provide an improved level of procedural efficiency as compared with titration sedation and thus offer a reasonable and costeffective alternative to anesthesia services.
Methods
We performed a retrospective analysis of colonoscopies done between April 2010 and April 2011 at the Duke University Medical Center endoscopy unit. This hospital-based endoscopy unit primarily serves outpatients, although procedures are occasionally performed on inpatients when needed. In addition, inpatients from neighboring hospitals are rarely transported to Duke for a particular procedure and transported back afterward. We excluded the following groups from our analysis: incomplete colonoscopies, colonoscopies performed with other procedures, colonoscopies with critical time stamps missing (sedation start, procedure start, and procedure finish), and patients who had more than 1 colonoscopy during the study period.
Procedural sedation is primarily provided by nurses who administer conscious sedation with fentanyl and midazolam under the supervision of the physician endoscopist; however, monitored anesthesia care using nurse anesthetists is also provided for several procedures, including endoscopic ultrasound, endoscopic retrograde cholangiopancreatography, and select general cases. Colonoscopies performed before mid-October 2010 were performed under a nurse-directed titration sedation policy, in which nurses administered incremental doses of fentanyl and midazolam every 2-3 minutes as per ASA guidelines until sedation was believed to be adequate to begin the procedure. Colonoscopies performed after mid-October 2010 were performed under a physician-directed bolus sedation policy, in which physicians directed the administration of fentanyl and midazolam guided by a weight-based dosing nomogram ( Figure 1 ).
Patient flow time stamps were collected on all patients by the nursing staff using ProVation MultiCaregiver software (Provation Medical, Minneapolis, MN). Data were collected uniformly by the nursing staff using standard events, including: (1) admit to preoperation, (2) assessment start, (3) patient ready for procedure, (4) patient in procedure room, (5) sedation start, (6) scope in, (7) scope to cecum, (8) scope out, (9) received in recovery, (10) ready for discharge, and (11) discharged.
Patient demographics were obtained from the Duke University Health System Enterprise Data Warehouse using the Duke Enterprise Data Unified Content Explorer, which is a Web-based query tool that provides direct access to the Enterprise Data Warehouse. 15 Available data in Duke Enterprise Data Unified Content Explorer in the Enterprise Data Warehouse included patient age, sex (male/female), race/ethnicity (white/nonwhite), smoking status (never/quit/current), and current alcohol use (yes/no).
Patient weight and height were manually extracted from the Duke University Health System electronic medical record. Sedation medication doses administered, presedation vital signs, intraprocedural vital signs, and the use of any sedation reversal agents were also manually abstracted from the Duke University Health System electronic medical record.
The study was approved by the Duke University Institutional Review Board.
Endoscopy Unit Efficiency Measures
To evaluate the impact of sedation policy on endoscopy unit efficiency, we based our efficiency measures on our prior work outlining a conceptual framework for endoscopy unit efficiency. 16 Our primary outcome was the total procedure time, which is the time interval from the administration of sedation to the completion of the colonoscopy. We chose this interval as primary because it defines the time the physician is involved in the case. We also analyzed several subintervals, including sedation time (sedation start to scope in), colonoscopy time (scope in to scope out), and recovery time (received in recovery to discharged).
Patient Experience Survey
As part of a unit-based quality improvement project, the nursing administration within the endoscopy unit administrated surveys (Supplementary Appendix) to patients in the month before the initiation of bolus sedation (September 2010) and in the 3 months immediately after initiation (October to December 2010). The survey was given to patients after their procedure with a request to return the survey by mail. Because of the quality improvement nature of the project and the time elapsed since administration, we do not have information on the number of patients receiving the survey and so cannot calculate a response rate. We do know that 204 surveys were returned from colonoscopy patients, 126 who had undergone colonoscopy with titration sedation and 78 with bolus sedation.
Adverse Events
Adverse events were defined as follows: (1) hypotension was defined as a mean arterial pressure <70 during the procedure and a 25% drop from the presedation baseline, (2) tachycardia was defined as a heart rate during the procedure >100 and a 25% increase from presedation baseline, (3) bradycardia was defined as a heart rate during the procedure <60 and a 25% decrease from the preprocedure baseline, and (4) hypoxia was defined as a desaturation to <90% during the procedure with a concomitant increase in supplemental oxygen. 
Statistical Analysis
Patient characteristics, medication dose, adverse events, and survey results (including discomfort and satisfaction) were described using frequency, mean, standard deviation, median, and interquartile range as appropriate. To determine whether there was significant difference between titration and bolus groups, we used the Pearson chi-square test for categorical variables and Wilcoxon rank sum test for continuous and ordinal categorical variables.
Time intervals were used to measure endoscopy unit efficiency. In addition to reporting mean (standard deviation) and median (interquartile range), we examined if there was significant difference in each time interval between participants who received bolus sedation versus titration sedation by using Wilcoxon rank sum test. To examine whether patients' characteristics modify the group differences, we used simple general linear regression with time interval as the dependent variable and sedation bolus versus titration along with age, gender, race, smoking status, alcohol consumption, body mass index, and ASA classification together as independent variables. To examine whether sedation method impacted the adverse event rate, we developed a logistic regression model with adverse event as the dependent variable and adjusted for these same independent variables.
We used SAS version 9.4 (SAS Institute, Inc, Cary, NC) for all analyses and a 2-tailed significance level of 0.05 for all statistical tests without adjusting for multiple comparisons.
Results
A total of 966 colonoscopies were performed in the titration sedation period (April to September 2010) and 699 in the bolus period (November 2010 to April 2011) by 1 of 22 faculty gastroenterologists. Table 1 shows the demographic characteristics of the 2 groups. Patients in the bolus sedation group were more likely to be white; they also had a lower mean body mass index (27.2 vs 28.0) and higher ASA score (2.0 vs 1.9). Although not statistically significant, there was also a trend toward a higher level of alcohol consumption in the bolus sedation group.
As demonstrated in Table 2 , the titration sedation group received a significantly larger total dose of both midazolam and fentanyl. This significance persisted after examining total doses received per unit weight. There was no difference between the 2 groups in the use of diphenhydramine as an adjunctive sedation agent (data not shown). Table 3 shows the endoscopy unit time stamps in the titration and bolus sedation groups. Patients in the bolus sedation group had a shorter sedation time (median, 6.0 min vs 13.0 min; P < .01), which also translated into a shorter time from sedation to discharge (median, 92.0 min vs 99.5 min; P < .01). Recovery time was not significantly different in the 2 groups (median, 52.0 min vs 53.0 min; P ¼ .07). Colonoscopy time was longer in the bolus sedation group as compared with titration (median, 25.0 min vs 24.0 min; P ¼ .03); however, the total procedure time remained longer in the titration group despite this (median, 31.0 vs 38.0). These findings were unchanged in a multivariate analysis adjusting for demographic and clinical variables where bolus sedation was associated with a 6.0 minute (95% confidence interval, 4.7-7.2) decrease in total procedure time. Table 4 shows the incidence of intraprocedural adverse events during the observed procedures. The incidence of significant bradycardia, tachycardia, and hypoxia was similar in both sedation groups in an unadjusted analysis. In a multivariate analysis, there was increased tachycardia in the titration group over the bolus sedation group. In both adjusted and unadjusted analyses, there was excess hypotension in the titration group when compared with the bolus sedation group. None of these adverse events necessitated administration of sedation reversal agents.
Patient survey findings are displayed in Table 5 . Notably, there was no difference detected in the amount of discomfort felt during the procedure or patients' overall satisfaction with the endoscopic sedation. Patients in the bolus sedation group were more likely to report remembering the start of the procedure (28.6% vs 13.6%; P < .01), being awake during the procedure (58.4% vs 40.0%; P ¼ .01) and remembering when the scope was removed (45.5% vs 24.0%; P < .01).
Discussion
In this retrospective analysis of a practice improvement intervention, we found that physician-directed bolus sedation for colonoscopy using a weight-based nomogram of fentanyl and midazolam improved endoscopy unit efficiency by allowing a faster onset to colonoscopy start, thus reducing the total procedure time when compared with a more traditional slow titration approach as advocated by the ASA. Furthermore, we found that this benefit in efficiency did not come at the expense of patient safety or patient satisfaction. In fact, patients with bolus sedation received less sedation per unit weight and experienced fewer intraprocedural adverse events than those receiving titration sedation.
Our results are similar to those of Morrow et al 11 who undertook the only published prospective randomized trial comparing bolus with titration for colonoscopy in 2000. In their trial, they found that rapid bolus with meperidine and midazolam resulted in a significantly decreased total physician time while providing equivalent patient comfort. Furthermore, they found that bolus sedation required less medication and caused less hypoxemia than the titration protocol. These findings mirror earlier studies in the United Kingdom of bolus sedation for upper gastrointestinal endoscopy, again demonstrating fewer adverse outcomes in the bolus group. 17, 18 Our findings augment those presented by Morrow et al 11 in 2 important ways. First, we evaluated the bolus sedation approach with fentanyl as opposed to meperidine. This is important given the widespread use of these 2 medications in endoscopy suites and evidence suggesting differences in endoscopy unit efficiency with these 2 narcotics when given in combination with midazolam. 19 Second, in contrast to the study by Morrow et al, 11 we included recovery time in our endoscopy unit efficiency metrics. Recovery time is an important metric to evaluate given that bottlenecks in unit flow may occur in the recovery bays. 20 Our expectation was that bolus sedation would decrease recovery time because these patients reported being more likely to remember the end of the procedure. However, we did not detect any difference in recovery time between the 2 groups. This may stem, in part, from hospital recovery policies mandating a minimum amount of recovery time after moderate sedation.
One of the most important questions that arise from the original study by Morrow et al 11 and our analysis is how a bolus sedation approach would compare with propofol. The use of propofol for sedation during colonoscopy is increasing in frequency with significant potential financial and safety consequences. [1] [2] [3] 10 Propofol has been shown to shorten sedation and recovery times as compared with a combination of midazolam plus narcotic, 5, 9 suggesting it improves endoscopy unit efficiency. However, in the key trials evaluated in these meta-analyses, 21 ,22 titration sedation Understandably, given the retrospective nature of the study, several limitations should be noted. First, the patient satisfaction findings are based on a small sample size. As such, we may not have had the power to detect meaningful differences between groups. Second, the sedation times in our study are longer than those reported in the clinical trials cited previously. For example, the sedation time in the midazolam and meperidine arm was 7.0 minutes in 1 study 21 and 6.1 minutes with midazolam and fentanyl in the other. 22 However, it should be noted that both of these studies were from the same institution and may not be reflective of sedation practices at many hospital-based endoscopy units. For example, a recent study from San Francisco General Hospital reported an average sedation time for colonoscopy of 11.2 minutes. 23 This time is more consistent with that reported by Morrow et al 11 of 11.0 minutes for titration and 3.0 minutes for the bolus group. The times reported in our analysis remain longer, perhaps reflecting the teaching environment or unique processes at our institution. For example, in our teaching facility, in some cases, physicians may have been outside of the procedure room during sedation and so some waiting time may be built into procedure start. Although it is possible these differences explain some of the differences in sedation time, it is unlikely to explain all. Finally, given the retrospective nature of this study and the fact that patient scheduling remained unchanged before and after the intervention, it is not possible to capture the impact that shorter procedure time had on patient throughput.
Limitations notwithstanding, we believe that our analysis has several unique strengths. This analysis is the first to follow up on the findings of Morrow et al 11 in 2000. It remains unclear to what extent their findings have been implemented, especially given that practice guidelines from the ASA continue to support a titration approach. Furthermore, our study is the only to specifically compare bolus with titration sedation using a combination of fentanyl and midazolam. We believe that additional prospective studies should be undertaken directly comparing bolus sedation with propofol with a definitive study including 3 arms: titration, bolus, and propofol. This study would answer several key questions and may help provide clarity to guidelines on conscious sedation in colonoscopy.
